Neurologie-Leitlinien

41 aktuelle Neurologie-Leitlinien von nationalen Behörden, europäischen Fachgesellschaften und HTA-Institutionen, über 12 Quellgruppen. eUvidence verankert Neurologie-Antworten an diesen Leitlinien; jeder Eintrag verlinkt auf die eigene Seite der herausgebenden Institution.

Europäische Fachgesellschaften· 5

• European Stroke Organisation (ESO) and European Association of Neurosurgical Societies (EANS) guideline on stroke due to spontaneous intracerebral haemorrhage

  ESO · European Stroke Organisation · 2025

• European Academy of Neurology (EAN) guideline on the management of amyotrophic lateral sclerosis in collaboration with European Reference Network for Neuromuscular Diseases (ERN EURO-NMD)

  EAN · European Academy of Neurology · 2024

• European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention - 2022 update

  EHF · European Headache Federation · 2022

• European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke

  ESO · European Stroke Organisation · 2021

• A European Academy of Neurology guideline on medical management issues in dementia

  EAN · European Academy of Neurology · 2020

Finnland· 2

• Epilepsy (Adults)

  Kaypa hoito · Finnish Medical Society Duodecim and the Finnish Neurological Society · 2020

• Brain Injuries

  Kaypa hoito · Finnish Medical Society Duodecim (in collaboration with multiple specialist societies) · 2017

Frankreich· 4

• Stroke: early management (alert, prehospital phase, initial hospital phase, indications for intravenous thrombolysis and mechanical thrombectomy)

  HAS · Haute Autorite de Sante · 2025 · recommendation

• Epilepsies: management of children and adults

  HAS · Haute Autorite de Sante · 2020 · recommendation

• Care pathway for patients with a neurocognitive disorder associated with Alzheimer's disease or a related disease

  HAS · Haute Autorite de Sante · 2018

• Care pathway guide: Parkinson's disease

  HAS · Haute Autorite de Sante · 2016

Deutschland· 6

• Dementias (S3 living guideline)

  DGN · Deutsche Gesellschaft fuer Neurologie / DGPPN · 2026

• Diagnosis and treatment of multiple sclerosis, neuromyelitis optica spectrum disorder and MOG-IgG-associated disease

  DGN · Deutsche Gesellschaft fuer Neurologie · 2025

• Therapy of the migraine attack and prophylaxis of migraine

  DGN · Deutsche Gesellschaft fuer Neurologie · 2024

• First epileptic seizure and epilepsies in adulthood

  DGN · Deutsche Gesellschaft fuer Neurologie · 2023

• Parkinson's disease

  DGN · Deutsche Gesellschaft fuer Neurologie · 2023

• Acute therapy of ischaemic stroke

  DGN · Deutsche Gesellschaft fuer Neurologie · 2022

Italien· 2

• Diagnosis and Treatment of Dementia and Mild Cognitive Impairment

  ISS · Istituto Superiore di Sanita · 2023

• Diagnosis and Therapy of Multiple Sclerosis in Adults

  SIN · Societa Italiana di Neurologia · 2022

Niederlande· 5

• Thrombolysis with alteplase in acute ischaemic stroke

  NVN · Nederlandse Vereniging voor Neurologie · 2021

• Disease-modifying treatment of multiple sclerosis

  NVN · Nederlandse Vereniging voor Neurologie · 2021

• Anti-seizure medication in epilepsy

  NVN · Nederlandse Vereniging voor Neurologie · 2020

• Pharmacological treatment of motor symptoms in Parkinson's disease

  NVN · Nederlandse Vereniging voor Neurologie · 2020

• Prophylactic treatment of migraine

  NVN · Nederlandse Vereniging voor Neurologie · 2018

Norwegen· 1

• National Clinical Guideline for Treatment and Rehabilitation of Stroke

  Helsedir · Norwegian Directorate of Health · 2017

Polen· 2

• Disease-Modifying Treatment of Multiple Sclerosis - Recommendations of the Multiple Sclerosis and Neuroimmunology Section of the Polish Neurological Society

  PTN · Polskie Towarzystwo Neurologiczne · 2023 · recommendation

• Diagnosis and Treatment of Epilepsy - Guidelines of the Epilepsy Section of the Polish Neurological Society

  PTN · Polskie Towarzystwo Neurologiczne · 2022

Portugal· 2

• Diagnostic and Therapeutic Approach to the Patient with Cognitive Decline or Dementia

  DGS · Direcao-Geral da Saude · 2023

• Stroke Green Channel in Adults

  DGS · Direcao-Geral da Saude · 2017

Spanien· 3

• Clinical Practice Guideline on the Management of Stroke in Primary Care

  GuiaSalud · Osteba (Servicio de Evaluacion de Tecnologias Sanitarias del Pais Vasco) / Ministerio de Sanidad · 2024

• Clinical Practice Guideline on Secondary Prevention of Stroke (Update)

  GuiaSalud · AETSA - Evaluacion de Tecnologias Sanitarias de Andalucia / Ministerio de Sanidad · 2023

• Clinical Practice Recommendations in Parkinson's Disease

  SAN · Sociedad Andaluza de Neurologia / Grupo Andaluz de Trastornos del Movimiento · 2022

Schweden· 3

• National Guidelines for Stroke Care - Support for Governance and Management

  Socialstyrelsen · National Board of Health and Welfare · 2020

• National Guidelines for Epilepsy Care - Support for Governance and Management

  Socialstyrelsen · National Board of Health and Welfare · 2019

• Pharmacological Treatment of Multiple Sclerosis - Treatment Recommendation

  Lakemedelsverket · Medical Products Agency · 2019 · recommendation

Vereinigtes Königreich· 6

• Epilepsies in children, young people and adults

  NICE · National Institute for Health and Care Excellence · 2022

• Multiple sclerosis in adults: management

  NICE · National Institute for Health and Care Excellence · 2022

• Stroke and transient ischaemic attack in over 16s: diagnosis and initial management

  NICE · National Institute for Health and Care Excellence · 2019

• Dementia: assessment, management and support for people living with dementia and their carers

  NICE · National Institute for Health and Care Excellence · 2018

• Parkinson's disease in adults

  NICE · National Institute for Health and Care Excellence · 2017

• Headaches in over 12s: diagnosis and management

  NICE · National Institute for Health and Care Excellence · 2012